Bronchoscopic Cryo-Immunotherapy of Lung Cancer

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 15, 2020

Primary Completion Date

April 9, 2024

Study Completion Date

April 9, 2024

Conditions

Advanced Non-small Cell Lung Cancer

Interventions

DEVICE

ERBOKRYO® CA - Cryosurgical Unit with Flexible ERBECRYO Probe, 1.9 mm outer diameter (ERBE Inc., Tubingen, Germany)

See BCI description.

Trial Locations (1)

NYU Langone Health, New York

All Listed Sponsors

lead

NYU Langone Health

OTHER

NCT04049474 - Bronchoscopic Cryo-Immunotherapy of Lung Cancer | Biotech Hunter | Biotech Hunter